ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

52
Analysis
Health CareNew Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bullishPacific Edge
02 Dec 2021 08:40Broker

Pacific Edge (PEB): 1H22 Result – Initial Impressions

Pacific Edge (PEB)1H22 Result – Initial Impressions Pacific Edge (PEB) reported a 1H22 NPAT loss of -NZ$9.0m, which was +NZ$0.4m better than our...

Logo
1k Views
Share
20 Oct 2021 08:05Broker

Company Coverage: Temporary Analyst Change

Company Coverage Temporary Analyst Change  We temporarily transfer coverage of the following companies to Matt Montgomerie due to...

Logo
279 Views
Share
bullishPacific Edge
01 Oct 2021 08:03Broker

Pacific Edge: Capital Raise

Pacific EdgeCapital Raise RESTRICTED Pacific Edge (PEB) has announced a capital raise, totalling up to NZ$80m, to accelerate execution of its...

Logo
1.2k Views
Share
bullishPacific Edge
30 Sep 2021 08:09Broker

Pacific Edge: Capital Raising

Pacific EdgeCapital Raising Pacific Edge (PEB) has announced a capital raise, totalling up to NZ$80m, to accelerate execution of its growth plans....

Logo
1.2k Views
Share
bullishPacific Edge
27 Jul 2021 21:46Issuer-paid

Pacific Edge - Termination of coverage

Edison Investment Research is terminating coverage on Kcell Joint Stock Company (KCEL), Locate Bio, Pacific Edge (PEB), Tungsten Corporation (TUNG)...

Share
x